Brodalumab and psoriatic arthritis: what patients should know

Someone whose skin improves may still have active joint or tendon inflammation, so skin and musculoskeletal symptoms need separate follow-up.

Brodalumab is a biologic medicine that blocks the interleukin-17 receptor A, reducing signals involved in psoriatic skin inflammation. Psoriatic arthritis can affect joints, the places where tendons attach to bone, fingers, toes and the spine. Joint pain, swelling or morning stiffness that persists despite clearer skin may indicate that the arthritis needs its own assessment and treatment plan.

Do not assume that every ache is inflammatory arthritis. A rheumatology review can examine the pattern of symptoms, check for tenderness or swelling and decide whether imaging or blood tests would clarify the cause.

If you take brodalumab and have joint symptoms, record which areas hurt or swell, how long morning stiffness lasts and whether movement helps. Share this with both your dermatologist and rheumatologist so they can coordinate treatment rather than changing the medicine independently.

Before each dose, report signs of infection and any new bowel symptoms. Do not start, stop or delay brodalumab without instructions from the prescribing clinician. Exercise and physiotherapy may support strength and movement, but they do not replace control of active inflammatory arthritis.

Contact the prescribing team promptly for fever, a worsening infection, persistent diarrhoea, abdominal pain, blood in the stool or a marked change in mood. Seek emergency help immediately for thoughts of self-harm, severe breathing difficulty, facial or throat swelling, or rapidly worsening illness.

Arrange a timely arthritis review if a joint becomes repeatedly swollen, morning stiffness is increasing, a finger or toe swells throughout, or pain is limiting walking, sleep or daily tasks.

Ask whether your symptoms suggest active psoriatic arthritis, who will monitor your skin and joints, and what infection screening or vaccinations are appropriate before and during treatment. You can also ask what options target both psoriasis and arthritis if joint inflammation remains active.